Jasper Hellweg
Stock Analyst at Argus Research
(4.06)
# 1,716
Out of 4,659 analysts
238
Total ratings
56.1%
Success rate
7.4%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintained: Buy | $360 → $460 | $425.28 | +8.16% | 7 | Aug 19, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $130 → $145 | $135.17 | +7.27% | 6 | Aug 10, 2026 | |
| NVO Novo Nordisk | Maintained: Hold | n/a | $45.71 | - | 8 | Aug 7, 2026 | |
| BMY Bristol-Myers Squibb Company | Upgraded: Buy | $75 | $66.05 | +13.55% | 5 | Aug 4, 2026 | |
| NVS Novartis AG | Maintained: Buy | $160 → $170 | $154.55 | +10.00% | 3 | Jul 24, 2026 | |
| BIIB Biogen | Maintained: Hold | n/a | $212.55 | - | 6 | Jul 10, 2026 | |
| SWX: ALC Alcon Inc. | Maintained: Buy | CHF 68.95 | CHF 60.34 | +14.26% | 5 | Jul 1, 2026 | |
| ELAN Elanco Animal Health | Maintained: Buy | n/a | $23.64 | - | 7 | Jun 23, 2026 | |
| GSK GSK plc | Maintained: Buy | n/a | $51.15 | - | 2 | Jun 8, 2026 | |
| ZTS Zoetis | Downgraded: Hold | n/a | $73.96 | - | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 → $250 | $258.92 | -3.45% | 5 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $55 | $55.52 | -0.94% | 3 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $345 → $560 | $518.27 | +8.05% | 11 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $62.96 | - | 14 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $810.24 | n/a | 13 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $143.44 | n/a | 7 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 → $100 | $188.29 | n/a | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $25.94 | n/a | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $36.58 | n/a | 9 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,225.73 | n/a | 4 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.17 | n/a | 4 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $60 | $44.97 | n/a | 3 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $465 → $550 | $528.19 | n/a | 11 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $125 | $125.09 | n/a | 8 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $70 | $123.47 | n/a | 6 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $26 | $4.96 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $285 → $225 | $181.84 | n/a | 6 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $322.18 | n/a | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $165 | $236.25 | n/a | 6 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $475 → $500 | $398.27 | n/a | 5 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $290 | $240.03 | n/a | 5 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $195 → $275 | $411.73 | n/a | 6 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 → $50 | $50.47 | n/a | 3 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.66 | n/a | 5 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $135 | $111.10 | n/a | 5 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $115 | $51.72 | n/a | 4 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.97 | n/a | 3 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $287.59 | n/a | 4 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $59.48 | n/a | 1 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $23.06 | n/a | 2 | Aug 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $220.01 | n/a | 1 | Aug 31, 2016 |
Amgen
Aug 19, 2026
Maintained: Buy
Price Target: $360 → $460
Current: $425.28
Upside: +8.16%
Merck & Co.
Aug 10, 2026
Reiterated: Buy
Price Target: $130 → $145
Current: $135.17
Upside: +7.27%
Novo Nordisk
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $45.71
Upside: -
Bristol-Myers Squibb Company
Aug 4, 2026
Upgraded: Buy
Price Target: $75
Current: $66.05
Upside: +13.55%
Novartis AG
Jul 24, 2026
Maintained: Buy
Price Target: $160 → $170
Current: $154.55
Upside: +10.00%
Biogen
Jul 10, 2026
Maintained: Hold
Price Target: n/a
Current: $212.55
Upside: -
Alcon Inc.
Jul 1, 2026
Maintained: Buy
Price Target: CHF 68.95
Current: CHF 60.34
Upside: +14.26%
Elanco Animal Health
Jun 23, 2026
Maintained: Buy
Price Target: n/a
Current: $23.64
Upside: -
GSK plc
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $51.15
Upside: -
Zoetis
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $73.96
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: $220 → $250
Current: $258.92
Upside: -3.45%
Apr 6, 2026
Upgraded: Buy
Price Target: $55
Current: $55.52
Upside: -0.94%
Mar 3, 2026
Rated: Buy
Price Target: $345 → $560
Current: $518.27
Upside: +8.05%
Jan 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $62.96
Upside: -
Jun 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $810.24
Upside: n/a
May 5, 2025
Reiterated: Buy
Price Target: $100 → $120
Current: $143.44
Upside: n/a
Mar 28, 2025
Maintained: Buy
Price Target: $150 → $100
Current: $188.29
Upside: n/a
Feb 24, 2025
Upgraded: Buy
Price Target: $40
Current: $25.94
Upside: n/a
Jan 30, 2025
Maintained: Buy
Price Target: $20
Current: $36.58
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: n/a
Current: $1,225.73
Upside: n/a
Jan 6, 2025
Maintained: Hold
Price Target: n/a
Current: $16.17
Upside: n/a
Jul 26, 2024
Maintained: Buy
Price Target: $55 → $60
Current: $44.97
Upside: n/a
Jun 17, 2024
Maintained: Buy
Price Target: $465 → $550
Current: $528.19
Upside: n/a
Apr 29, 2024
Maintained: Buy
Price Target: $105 → $125
Current: $125.09
Upside: n/a
Apr 25, 2024
Maintained: Buy
Price Target: $90 → $70
Current: $123.47
Upside: n/a
Dec 7, 2022
Upgraded: Buy
Price Target: $26
Current: $4.96
Upside: n/a
Oct 24, 2022
Maintained: Buy
Price Target: $285 → $225
Current: $181.84
Upside: n/a
Sep 19, 2022
Downgraded: Hold
Price Target: n/a
Current: $322.18
Upside: n/a
Aug 17, 2022
Maintained: Buy
Price Target: $135 → $165
Current: $236.25
Upside: n/a
Feb 7, 2022
Maintained: Buy
Price Target: $475 → $500
Current: $398.27
Upside: n/a
Sep 10, 2021
Maintained: Buy
Price Target: $260 → $290
Current: $240.03
Upside: n/a
Aug 2, 2021
Maintained: Buy
Price Target: $195 → $275
Current: $411.73
Upside: n/a
Jun 7, 2021
Maintained: Buy
Price Target: $43 → $50
Current: $50.47
Upside: n/a
May 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $4.66
Upside: n/a
May 3, 2021
Maintained: Buy
Price Target: $95 → $135
Current: $111.10
Upside: n/a
Jun 12, 2020
Maintained: Buy
Price Target: $135 → $115
Current: $51.72
Upside: n/a
Apr 17, 2020
Downgraded: Hold
Price Target: n/a
Current: $12.97
Upside: n/a
Mar 24, 2020
Downgraded: Hold
Price Target: n/a
Current: $287.59
Upside: n/a
Oct 30, 2019
Downgraded: Hold
Price Target: n/a
Current: $59.48
Upside: n/a
Aug 15, 2019
Upgraded: Buy
Price Target: $40
Current: $23.06
Upside: n/a
Aug 31, 2016
Downgraded: Hold
Price Target: n/a
Current: $220.01
Upside: n/a